Trials / Conditions / Recurrent or Metastatic
Recurrent or Metastatic
3 registered clinical trials studyying Recurrent or Metastatic — 1 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Recruiting | Camrelizumab Plus Fluzoparib for TP-53 Mutated Endometrial Cancer NCT06413992 | Cancer Institute and Hospital, Chinese Academy of Medical Sciences | Phase 2 |
| Active Not Recruiting | KL-A167 Injection Combined With Cisplatin and Gemcitabine vs Placebo Combined With Cisplatin and Gemcitabine i NCT05294172 | Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. | Phase 3 |
| Completed | KL-A167 Injection in Recurrent or Metastatic Nasopharyngeal Carcinoma NCT03848286 | Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. | Phase 2 |